Made in Africa: Immunogenicity and Efficacy of a Locally Produced COVID-19 mRNA Vaccine Compared to the Licensed BNT162b2 mRNA Vaccine

SSRN Electronic Journal 2026 Preprint Open access

Read full text
Authors: Pia Steigler, Ntombi Benede, Thandeka Moyo-Gwete, See PDF
DOI: 10.2139/ssrn.6050467
Cited by: 0

Fields of Study & Subjects

SARS-CoV-2 and COVID-19 Research vaccines and immunoinformatics approaches Vaccine Coverage and Hesitancy

Publication details

Journal / source
SSRN Electronic Journal
Publication date
1 January 2026
Document type
Preprint